Title : Involvement of the K+-Cl- co-transporter KCC2 in the sensitization to morphine-induced hyperlocomotion under chronic treatment with zolpidem in the mesolimbic system.

Pub. Date : 2013 Jun

PMID : 23565710






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 On the other hand, pre-treatment with furosemide (a KCC2 inhibitor) suppressed the enhancing effects of zolpidem on morphine-induced hyperlocomotion. Furosemide solute carrier family 12 member 5 Homo sapiens